CFTR modulates the function of renal ROMK2 K+ channels by enhancing their sensitivity to the sulfonylurea compound glibenclamide.
Answers are grounded in this paper and cite their sources.
CFTR-ROMK2 coexpression may heighten glibenclamide effects on renal K+ channels; hypothesis-generating for cystic fibrosis channel modulation.
We demonstrate here that coexpression of ROMK2, an inwardly rectifying ATP-sensitive renal K+ channel (IKATP) with cystic fibrosis transmembrane regulator (CFTR) significantly enhances the sensitivity of ROMK2 to the sulfonylurea compound glibenclamide. When expressed alone, ROMK2 is relatively insensitive to glibenclamide. The interaction between ROMK2, CFTR, and glibenclamide is modulated by altering the phosphorylation state of either ROMK2, CFTR, or an associated protein, as exogenous MgATP and the catalytic subunit of protein kinase A significantly attenuate the inhibitory effect of glibenclamide on ROMK2. Thus CFTR, which has been demonstrated to interact with both Na+ and Cl- channels in airway epithelium, modulates the function of renal ROMK2 K+ channels.
No takes yet. Share an insight, caveat, or question.
McNicholas et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: